Please login to the form below

Not currently logged in
Email:
Password:

Dr Antoine Yver moves from AstraZeneca to Daiichi Sankyo

He becomes global head, oncology research and development

Daiichi Sankyo Dr Antoine YverDaiichi Sankyo has appointed Dr Antoine Yver to the newly-created position of global head, oncology research and development.

Reporting directly to Dr Glenn Gormley, Daiichi Sankyo's president and global head of research and development, Dr Yver will oversee the entirety of the firm's global research and development in the oncology therapeutic area.

Dr Gormley said: “Antoine brings a strong track record of extensive scientific leadership in many facets of global oncology pharmaceutical research and development along with tremendous passion for science and patients.

“We are confident that Antoine will provide great leadership and strategic insights in this new role, which underscores Daiichi Sankyo's commitment to the fight against cancer.”

Dr Yver moves from AstraZeneca, where he has served as senior vice president and head of oncology global medicines development as well as leading its global medicines development in China since 2012.

Prior to this, he has held senior management roles in oncology research at Aventis, Johnson & Johnson and Schering-Plough.

Dr Yver said: “I'm excited to join such a respected company and further build its presence in this important field.

“I have been most impressed by the quality of science at Daiichi Sankyo and the company's strong commitment towards becoming an innovator in bringing new therapeutic options to people living with cancer.”

6th April 2016

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

CBC
Building Europe’s next breakthrough biotechs
Start Codon's Daniel Rooke on fostering biotech success in Cambridge, UK...
Tactful screening & participant sensitivity
Screening participants can involve asking personal questions that could be perceived as intrusive. Here CMR explores the implications of such lines of questioning....
Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...

Infographics